Request for quotation
Supplier Contact
 | |
| Supplier Name | MedChemExpress (MCE) |
| Contact | sales |
| Tel | 609-228-6898 |
| Mobile | 609-228-6898 |
| sales@medchemexpress.com; tech@medchemexpress.com | |
| Website | https://www.medchemexpress.com/ |
| Product Name | Lenalidomide |
| Synonyms | CC-5013 Revlimi Revlimid enalidomide Lenalidomid Lenalidomide LenalidoMide(CC-5013,RevliMid) |
| CAS | 191732-72-6 |
| EINECS | 691-297-1 |
| Chemical Formula | C13H13N3O3 |
| Molecular Weight | 259.26 |
| inchi | InChI=1/C13H13N3O3/c14-9-3-1-2-7-8(9)6-16(13(7)19)10-4-5-11(17)15-12(10)18/h1-3,10H,4-6,14H2,(H,15,17,18) |
| Package | 5 mg;10 mg;25 mg;50 mg;100 mg |
| Price | Email to quote |
| Descriptions | Lenalidomide (Standard) MedChemExpress (MCE) HY-A0003R 98% Please store the product under the recommended conditions in the Certificate of Analysis. Lenalidomide (Standard) is the analytical standard of Lenalidomide. This product is intended for research and analytical applications. Lenalidomide (CC-5013), a derivative of Thalidomide, acts as molecular glue. Lenalidomide is an orally active immunomodulator. Lenalidomide (CC-5013) is a ligand of ubiquitin E3 ligase cereblon (CRBN), and it causes selective ubiquitination and degradation of two lymphoid transcription factors, IKZF1 and IKZF3, by the CRBN-CRL4 ubiquitin ligase. Lenalidomide (CC-5013) specifically inhibits growth of mature B-cell lymphomas, including multiple myeloma, and induces IL-2 release from T cells. |
| Last Update | 2025-04-01 14:45:47 |
MedChemExpress (MCE) also provides
Category: Signaling Pathways
CAS: 2341840-99-9
Last Update: 2025-04-01 14:45:47
CAS: 2341840-99-9
Last Update: 2025-04-01 14:45:47
Category: Signaling Pathways
CAS: 810677-36-2
Last Update: 2025-04-01 14:45:47
CAS: 810677-36-2
Last Update: 2025-04-01 14:45:47
Category: Signaling Pathways
CAS: 910808-11-6
Last Update: 2025-04-01 14:45:47
CAS: 910808-11-6
Last Update: 2025-04-01 14:45:47
Category: Signaling Pathways
CAS: 624733-88-6
Last Update: 2025-04-01 14:45:47
CAS: 624733-88-6
Last Update: 2025-04-01 14:45:47
Category: Signaling Pathways
CAS: 339071-18-0
Last Update: 2025-04-01 14:45:47
CAS: 339071-18-0
Last Update: 2025-04-01 14:45:47
Category: Signaling Pathways
CAS: 705260-08-8
Last Update: 2025-04-01 14:45:47
CAS: 705260-08-8
Last Update: 2025-04-01 14:45:47
Category: Signaling Pathways
CAS: 853910-02-8
Last Update: 2025-04-01 14:45:47
CAS: 853910-02-8
Last Update: 2025-04-01 14:45:47
Category: Signaling Pathways
CAS: 312752-85-5
Last Update: 2025-04-01 14:45:47
CAS: 312752-85-5
Last Update: 2025-04-01 14:45:47